Install our extension to search inside any video instantly.

New pill could lower bad cholesterol as Louisiana faces higher-than-average rates

Added:
295 views6likes3:09wwltvOriginal Release: 2026-07-21

The FDA-approved oral PCSK9 inhibitor Lipfendra can reduce LDL (bad) cholesterol by nearly 60%, offering an alternative to statins and injectable PCSK9 inhibitors; lower LDL levels are associated with reduced risk of cardiovascular events including stroke, heart attack, and kidney disease, as LDL contributes to arterial plaque formation while HDL helps remove it.